CMC strategy
Clear development plans connecting science, regulation, cost and timelines.
Vaccine & biopharma development
Turning complex science into manufacturable medicines.
Senior CMC leadership and hands-on technical expertise to move vaccines and biologics from development strategy to clinical manufacture.
Start a conversation ↗
UK-based
Supporting global programmes
Science→Impact
Strategy
Scale-up
Clinical supply
How we help
Expert support where it matters most.
Process & scale-up
Hands-on support across process, analytics, formulation and clinical manufacture.
Technology transfer
CDMO selection, transfer leadership and rapid resolution of manufacturing issues.
Our team
Specialist expertise, working as one.
A multidisciplinary team supporting vaccine and biologics programmes from research through delivery.
Quality & compliance
Global QA/QC, inspection readiness, quality systems, investigations and CAPA.
Bioprocess & technology transfer
Scale-up, GMP manufacture, CDMO transfer and end-to-end process delivery.
Pre-clinical research
Translational research leadership across infectious diseases, partnerships and funded programmes.
Project & regulatory operations
Cross-functional delivery, health-authority responses, labelling and regulatory documentation.
Finance & administration
Financial reporting, budgeting and efficient administrative support for complex programmes.
20+years in vaccines
and biopharma
and biopharma
10+products progressed
towards market
towards market
Globalregulatory and
CDMO experience
CDMO experience
Viral vectors · Proteins & VLPs · Live & inactivated vaccines · mRNA